Johnson & Johnson (JNJ) 104.57 $JNJ
My K.I.S.S. Dividend Portfolio: 4th Quarter 2014 Update And Year-End Review
The Part-time Investor - at Seeking Alpha - Thu Jan 01, 7:17AM CST
ARLP: 43.05 (+0.24), UTX: 115.00 (-1.20), OKE: 49.79 (-0.17), SYY: 39.69 (-0.57), WMT: 85.88 (-0.91), DEO: 114.09 (-0.28), UGI: 37.98 (-0.90), SPY: 205.54 (-2.06), TGT: 75.91 (+0.20), DE: 88.47 (-0.99), MSFT: 46.45 (-0.57), BBL: 43.00 (-0.37), WPZ: 44.75 (-0.44), HRS: 71.82 (-0.97), HAS: 54.99 (-0.04), NSC: 109.61 (-1.21), COP: 69.06 (-0.87), WFC: 54.82 (-0.60), CSX: 36.23 (-0.20), BA: 129.98 (-1.85), TUP: 63.00 (-0.84), CBRL: 140.76 (+0.29), AVA: 35.35 (-0.98), WPC: 70.10 (-1.55), BPL: 75.66 (-0.99), MCD: 93.70 (-0.55), CVX: 112.18 (-0.93), SDY: 78.80 (-0.91), FLIC: 28.37 (+0.23), NVS: 92.66 (-0.55),
76.90 (-1.40), KMI: 42.31 (-0.19), GD: 137.62 (-2.01), GE: 25.27 (-0.30), BDX: 139.16 (-0.77), LMT: 192.57 (-2.86), MDT: 72.20 (-0.87), DLR: 66.30 (-0.77), RTN: 108.17 (-1.71), PTY: 15.90 (-0.63), O: 47.71 (-1.20), WEC: 52.74 (-0.97), PAA: 51.32 (-0.29), PEP: 94.56 (-1.40), JNJ: 104.57 (-0.79), CINF: 51.83 (-0.61), PAYX: 46.17 (-0.69), NUS: 43.70 (-0.58), QCOM: 74.33 (-0.69), NHI: 69.96 (-1.23), APD: 144.23 (-2.21), EMR: 61.73 (-0.64), SO: 49.11 (-0.66), ITW: 94.70 (-1.37), DRI: 58.63 (-0.16), NLY: 10.81 (-0.17), BIP: 41.87 (+0.19), OHI: 39.07 (-1.22), PG: 91.09 (-1.31), AFL: 61.09 (-0.89), LLL: 126.21 (-1.88)
12 Of The Safest Dividend Aristocrats
Dividend Yield - at Seeking Alpha - Thu Jan 01, 5:18AM CST
Happy New Year! It was a fantastic year 2014 and I hope you've also generated a good performance. I hope that this year can also produce a solid return for my portfolio despite the fact that many analysts are scared about the current market...
SWK: 96.08 (-0.64), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), ADP: 83.37 (-0.74), GPC: 106.57 (-1.18), TROW: 85.86 (-1.05), EMR: 61.73 (-0.64), XOM: 92.45 (-0.57), DOV: 71.72 (-1.75), CVX: 112.18 (-0.93), ITW: 94.70 (-1.37), AFL: 61.09 (-0.89)
Retirement: Income Only Or Total Return?
FinancialDave - at Seeking Alpha - Thu Jan 01, 4:19AM CST
JNJ: 104.57 (-0.79), BRK.B: 150.15 (-1.94)
Final Glance: Medical Devices companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
Final Glance: Pharmaceuticals companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Idera Gets Orphan Drug Status for its Oncology Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:15PM CST
Idera Pharmaceuticals (IDRA) announced that the FDA has granted orphan drug designation to IMO-8400.
JNJ: 104.57 (-0.79), PCYC: 122.26 (-0.32), IDRA: 4.41 (+0.05), AFFX: 9.87 (-0.12)
These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 341.61 (-1.62), MDVN: 99.61 (+0.72), JNJ: 104.57 (-0.79), AMZN: 310.35 (+0.05), JPM: 62.58 (-0.57), GILD: 94.26 (-1.02), AGIO: 112.04 (-0.13), AAPL: 110.38 (-2.14), XLRN: 38.96 (+1.30), CELG: 111.86 (-1.68)
How To Profit From Special Dividends
at The Street - Wed Dec 31, 10:47AM CST
By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" Sign up for our free daily newsletter Near the end of the year some companies announce special dividends. The pr...
JNJ: 104.57 (-0.79), XOM: 92.45 (-0.57), GM: 34.91 (-0.18), KLAC: 70.32 (-0.87), BA: 129.98 (-1.85)
Early Glance: Pharmaceuticals companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Early Glance: Medical Devices companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
Johnson & Johnson (JNJ) Approaches New Upside Target of $106.15
Comtex SmarTrend(R) - Wed Dec 31, 8:59AM CST
Shares of Johnson & Johnson (NYSE:JNJ) opened today above their pivot of $105.41 and have already reached the first level of resistance at $105.75. Investors may be interested in a cross of the next upside pivot targets of $106.15 and $106.89.
JNJ: 104.57 (-0.79)
How I Earned 17% Compound Annual Return For 6 Years
Michael Hooper - at Seeking Alpha - Wed Dec 31, 6:51AM CST
RAI: 64.27 (-0.77), JNJ: 104.57 (-0.79), CHD: 78.81 (-0.83), SAM: 289.54 (+0.93), AAPL: 110.38 (-2.14), UNP: 119.13 (-1.12), CL: 69.19 (-0.85)
Portfolio Strategy For Someone Just Starting Out
Financially Free Investor - at Seeking Alpha - Wed Dec 31, 6:30AM CST
KO: 42.22 (-0.54), HCP: 44.03 (-0.66), PDI: 30.74 (+0.39), PCI: 20.65 (+0.20), XOM: 92.45 (-0.57), O: 47.71 (-1.20), DSE: 14.17 (+0.21), KYN: 38.18 (-0.34), T: 33.59 (-0.49), JNJ: 104.57 (-0.79), NMZ: 13.40 (-0.03), RFI: 13.20 (-0.04), UTF: 22.72 (-0.15), PFF: 39.44 (+0.05), PG: 91.09 (-1.31), VZ: 46.78 (-0.55)
Can DGI Aristocrats Beat The Market (Part 2)?
Seng Hong Teoh - at Seeking Alpha - Tue Dec 30, 5:24PM CST
KO: 42.22 (-0.54), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), SPY: 205.54 (-2.06), KMB: 115.54 (-1.81), XOM: 92.45 (-0.57), WMT: 85.88 (-0.91), MCD: 93.70 (-0.55), PG: 91.09 (-1.31), CL: 69.19 (-0.85)
Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:00PM CST
Gilead Sciences, Inc. announced that it has expanded its agreement with Janssen R&D Ireland, a subsidiary of Johnson & Johnson.
AGN: 212.59 (-0.81), JNJ: 104.57 (-0.79), ACT: 257.41 (-2.16), GILD: 94.26 (-1.02)
Midday Glance: Pharmaceuticals companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Midday Glance: Medical Devices companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Dec 30, 9:41AM CST
Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86)
My K.I.S.S. Dividend Portfolio: 4th Quarter 2014 Update And Year-End Review
The Part-time Investor - at Seeking Alpha - Thu Jan 01, 7:17AM CST
ARLP: 43.05 (+0.24), UTX: 115.00 (-1.20), OKE: 49.79 (-0.17), SYY: 39.69 (-0.57), WMT: 85.88 (-0.91), DEO: 114.09 (-0.28), UGI: 37.98 (-0.90), SPY: 205.54 (-2.06), TGT: 75.91 (+0.20), DE: 88.47 (-0.99), MSFT: 46.45 (-0.57), BBL: 43.00 (-0.37), WPZ: 44.75 (-0.44), HRS: 71.82 (-0.97), HAS: 54.99 (-0.04), NSC: 109.61 (-1.21), COP: 69.06 (-0.87), WFC: 54.82 (-0.60), CSX: 36.23 (-0.20), BA: 129.98 (-1.85), TUP: 63.00 (-0.84), CBRL: 140.76 (+0.29), AVA: 35.35 (-0.98), WPC: 70.10 (-1.55), BPL: 75.66 (-0.99), MCD: 93.70 (-0.55), CVX: 112.18 (-0.93), SDY: 78.80 (-0.91), FLIC: 28.37 (+0.23), NVS: 92.66 (-0.55),
76.90 (-1.40), KMI: 42.31 (-0.19), GD: 137.62 (-2.01), GE: 25.27 (-0.30), BDX: 139.16 (-0.77), LMT: 192.57 (-2.86), MDT: 72.20 (-0.87), DLR: 66.30 (-0.77), RTN: 108.17 (-1.71), PTY: 15.90 (-0.63), O: 47.71 (-1.20), WEC: 52.74 (-0.97), PAA: 51.32 (-0.29), PEP: 94.56 (-1.40), JNJ: 104.57 (-0.79), CINF: 51.83 (-0.61), PAYX: 46.17 (-0.69), NUS: 43.70 (-0.58), QCOM: 74.33 (-0.69), NHI: 69.96 (-1.23), APD: 144.23 (-2.21), EMR: 61.73 (-0.64), SO: 49.11 (-0.66), ITW: 94.70 (-1.37), DRI: 58.63 (-0.16), NLY: 10.81 (-0.17), BIP: 41.87 (+0.19), OHI: 39.07 (-1.22), PG: 91.09 (-1.31), AFL: 61.09 (-0.89), LLL: 126.21 (-1.88) 12 Of The Safest Dividend Aristocrats
Dividend Yield - at Seeking Alpha - Thu Jan 01, 5:18AM CST
Happy New Year! It was a fantastic year 2014 and I hope you've also generated a good performance. I hope that this year can also produce a solid return for my portfolio despite the fact that many analysts are scared about the current market...
SWK: 96.08 (-0.64), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), ADP: 83.37 (-0.74), GPC: 106.57 (-1.18), TROW: 85.86 (-1.05), EMR: 61.73 (-0.64), XOM: 92.45 (-0.57), DOV: 71.72 (-1.75), CVX: 112.18 (-0.93), ITW: 94.70 (-1.37), AFL: 61.09 (-0.89)
Retirement: Income Only Or Total Return?
FinancialDave - at Seeking Alpha - Thu Jan 01, 4:19AM CST
JNJ: 104.57 (-0.79), BRK.B: 150.15 (-1.94)
Final Glance: Medical Devices companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
Final Glance: Pharmaceuticals companies
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Idera Gets Orphan Drug Status for its Oncology Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:15PM CST
Idera Pharmaceuticals (IDRA) announced that the FDA has granted orphan drug designation to IMO-8400.
JNJ: 104.57 (-0.79), PCYC: 122.26 (-0.32), IDRA: 4.41 (+0.05), AFFX: 9.87 (-0.12)
These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 341.61 (-1.62), MDVN: 99.61 (+0.72), JNJ: 104.57 (-0.79), AMZN: 310.35 (+0.05), JPM: 62.58 (-0.57), GILD: 94.26 (-1.02), AGIO: 112.04 (-0.13), AAPL: 110.38 (-2.14), XLRN: 38.96 (+1.30), CELG: 111.86 (-1.68)
How To Profit From Special Dividends
at The Street - Wed Dec 31, 10:47AM CST
By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" Sign up for our free daily newsletter Near the end of the year some companies announce special dividends. The pr...
JNJ: 104.57 (-0.79), XOM: 92.45 (-0.57), GM: 34.91 (-0.18), KLAC: 70.32 (-0.87), BA: 129.98 (-1.85)
Early Glance: Pharmaceuticals companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Early Glance: Medical Devices companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
Johnson & Johnson (JNJ) Approaches New Upside Target of $106.15
Comtex SmarTrend(R) - Wed Dec 31, 8:59AM CST
Shares of Johnson & Johnson (NYSE:JNJ) opened today above their pivot of $105.41 and have already reached the first level of resistance at $105.75. Investors may be interested in a cross of the next upside pivot targets of $106.15 and $106.89.
JNJ: 104.57 (-0.79)
How I Earned 17% Compound Annual Return For 6 Years
Michael Hooper - at Seeking Alpha - Wed Dec 31, 6:51AM CST
RAI: 64.27 (-0.77), JNJ: 104.57 (-0.79), CHD: 78.81 (-0.83), SAM: 289.54 (+0.93), AAPL: 110.38 (-2.14), UNP: 119.13 (-1.12), CL: 69.19 (-0.85)
Portfolio Strategy For Someone Just Starting Out
Financially Free Investor - at Seeking Alpha - Wed Dec 31, 6:30AM CST
KO: 42.22 (-0.54), HCP: 44.03 (-0.66), PDI: 30.74 (+0.39), PCI: 20.65 (+0.20), XOM: 92.45 (-0.57), O: 47.71 (-1.20), DSE: 14.17 (+0.21), KYN: 38.18 (-0.34), T: 33.59 (-0.49), JNJ: 104.57 (-0.79), NMZ: 13.40 (-0.03), RFI: 13.20 (-0.04), UTF: 22.72 (-0.15), PFF: 39.44 (+0.05), PG: 91.09 (-1.31), VZ: 46.78 (-0.55)
Can DGI Aristocrats Beat The Market (Part 2)?
Seng Hong Teoh - at Seeking Alpha - Tue Dec 30, 5:24PM CST
KO: 42.22 (-0.54), MMM: 164.32 (-1.52), JNJ: 104.57 (-0.79), SPY: 205.54 (-2.06), KMB: 115.54 (-1.81), XOM: 92.45 (-0.57), WMT: 85.88 (-0.91), MCD: 93.70 (-0.55), PG: 91.09 (-1.31), CL: 69.19 (-0.85)
Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:00PM CST
Gilead Sciences, Inc. announced that it has expanded its agreement with Janssen R&D Ireland, a subsidiary of Johnson & Johnson.
AGN: 212.59 (-0.81), JNJ: 104.57 (-0.79), ACT: 257.41 (-2.16), GILD: 94.26 (-1.02)
Midday Glance: Pharmaceuticals companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 104.57 (-0.79), BAX: 73.29 (-0.73), PFE: 31.15 (-0.23), BMY: 59.03 (-0.36)
Midday Glance: Medical Devices companies
AP - Tue Dec 30, 12:24PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 113.42 (-1.15), JNJ: 104.57 (-0.79), MDT: 72.20 (-0.87), BAX: 73.29 (-0.73)
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Dec 30, 9:41AM CST
Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86)
